Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial

Bibliography

• Coluzzi F, Mattia C. Oxycodone. Pharmacological profile and clinical data in chronic pain management. Minerva Anestesiol 2005;71(7-8):451-60
   PubMedGoogle Scholar
• Mucci-LoRusso P, Berman BS, Silberstein PT, et al. Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study. Eur J Pain 1998;2(3):239-49
   PubMed Web of Science ®Google Scholar
• Kalso E. Oxycodone. J Pain Symptom Manage 2005;29(5 Suppl):S47-56
   PubMed Web of Science ®Google Scholar
• Watson CP, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003;105(1-2):71-8
   PubMed Web of Science ®Google Scholar
• Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003;60(6):927-34
   PubMed Web of Science ®Google Scholar
• Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998;50(6):1837-41
   PubMed Web of Science ®Google Scholar
• Ballantyne JC. Opioid analgesia: perspectives on right use and utility. Pain Physician 2007;10(3):479-91
   PubMedGoogle Scholar
• Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 2001;182(5A Suppl):11S-8S
   PubMed Web of Science ®Google Scholar
• Coluzzi F, Pappagallo M. Opioid therapy for chronic noncancer pain: practice guidelines for initiation and maintenance of therapy. Minerva Anestesiol 2005;71(7-8):425-33
   PubMedGoogle Scholar
• Bell TJ, Panchal SJ, Miaskowski C, et al. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med 2008:DOI: 10.1111/j.526-4637.2008.00495.x
   PubMedGoogle Scholar
• Cook S, Bell T, Sweeney C, et al. Impact on quality of life of constipation-associated GI symptoms related to opioid treatment in chronic pain patients: PAC-QOL results from the opioid survey [abstract 883]. J Pain 2007;8(4 Suppl 1):S71
   Google Scholar
• Annunziata K, Bell T. Impact of opioid-induced constipation on healthcare resource utilisation and patient functioning [abstract 659]. Eur J Pain 2006;10(Suppl S1):S172
   Google Scholar
• Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003;63(7):649-71
   PubMed Web of Science ®Google Scholar
• Liu M, Wittbrodt E. Low-dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Symptom Manage 2002;23(1):48-53
   PubMed Web of Science ®Google Scholar
• Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001;19(9):2542-54
   PubMed Web of Science ®Google Scholar
• Holzer P. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans. Neurosci Lett 2004;361(1-3):192-5
   PubMed Web of Science ®Google Scholar
• Sykes NP. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer. Palliat Med 1996;10(2):135-44
   PubMed Web of Science ®Google Scholar
• Choi YS, Billings JA. Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation. J Pain Symptom Manage 2002;24(1):71-90
   PubMed Web of Science ®Google Scholar
• De Schepper HU, Cremonini F, Park MI, Camilleri M. Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil 2004;16(4):383-94
   PubMed Web of Science ®Google Scholar
• Meissner W, Leyendecker P, Mueller-Lissner S, et al. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain 2008:doi: 10.1016/j.ejpain.2008.06.012
   PubMedGoogle Scholar
• Vondrackova D, Leyendecker P, Meissner W, et al. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain. J Pain 2008;9(12):1144-54
   PubMed Web of Science ®Google Scholar
• Simpson K, Leyendecker P, Hopp M, et al. A randomized double-blind trial of combined prolonged release oxycodone and naloxone in patients with moderate-to-severe noncancer pain. Curr Med Res Opin 2008;24(12):3503-12
   PubMed Web of Science ®Google Scholar
• Committee for Proprietary Medicinal Products (CPMP). Note for Guidance on Clinical Investigation of Medicinal Products for treatment of nociceptive pain (CPMP/EWP/612/00). London: EMEA, 2002
   Google Scholar
• The World Medical Association. Declaration of Helsinki. 2002
   Google Scholar
• International conference on harmonization (ICH). Guidelines on good clinical practice. 1997
   Google Scholar
• European parliament and council of the European Union. Clinical Trials Directive 2001/20/EC. OJ L 2001;121:34-44
   Google Scholar
• Frank L, Kleinman L, Farup C, et al. Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol 1999;34(9):870-7
   PubMed Web of Science ®Google Scholar
• Frank L, Flynn J, Rothman M. Use of a self-report constipation questionnaire with older adults in long-term care. Gerontologist 2001;41(6):778-86
   PubMed Web of Science ®Google Scholar
• Drossman DA, Corazziari E, Talley NJ, et al. ROME II. Second edition. The functional gastrointestinal disorders. Diagnosis, pathophysiology and treatment: a multinational consensus. McLean, VA: Degnon Associates, 2000
   Google Scholar
• Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997;32(9):920-4
   PubMed Web of Science ®Google Scholar
• Leyendecker P, Hopp M, Bosse B, et al. Bowel function index (BFI), a new validated questionnaire for assessing opioid induced constipation. IASP congress on pain; 2008; Glasgow; 2008. p. Poster presentation
   Google Scholar
• Handelsman L, Cochrane KJ, Aronson MJ, et al. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987;13(3):293-308
   PubMed Web of Science ®Google Scholar
• Rome Foundation. Guidelines – Rome III diagnostic criteria for functional gastrointestinal disorders. J Gastrointestin Liver Dis 2006;15(3):307-12
   PubMedGoogle Scholar